Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Covaxin, a vaccine developed in India, was found to have a 77.8 per cent efficacy rate against symptomatic Covid-19, said The Lancet
First Published: Nov 12 2021 | 6:43 AM IST